Reebok Rolls Out New Delta Logo A-B Pushing For Opening Day Nat'l Holiday Reebok Taps Venables Bell For Global Creative Reebok Drops DDB Amid Creative Review Adidas May Replace Reebok In NHL Bud Light Hotel Dwarfs Previous Efforts Bud Light Taps Bruce Smith For PSA Could Adidas Replace Reebok On NHL Jerseys? Reebok Launching "Fitness In Motion" Campaign ATP Inks Michelob Ultra Deal In U.S.
Upcoming Conferences and Events
SBD/6/Sponsorships Advertising Marketing
COMPANY WATCH: COORS SLUMPS, COKE SIGNS UP, REEBOK PROFILE
Published July 6, 1995
In the current FORTUNE, Eric Schonfeld writes that "about the only thing Adolph Coors can do to make Wall Street change its tepid outlook on the stock is, as one industry observer puts it, 'discover a cure for cancer.'" Second quarter earnings per share fell $.40 from $.63 during the same period last year. "Costlier aluminum cans and stiffer pricing are guzzling profits." Coors is "a distant third behind" A-B, and Miller in an industry "unlikely to grow more than 1% this year," and Beer Marketer's Insight reports that Coors' market share has remained "stalled" at 10%. Schonfeld: "Coors needs a hit" (FORTUNE, 7/27). COKE SIGNS A BLOCKBUSTER: Blockbuster Entertainment has formed an agreement for exclusive rights to Coca-Cola soft drinks at all Blockbuster Entertainment locations worldwide for a five- year period (AD AGE ONLINE, 7/6). REEBOK: Reebok is the focus of USA TODAY's "Company Spotlight." Although the company has "been caught flat-footed in the athletic shoe market," Liz Green writes that "shoes will be introduced at a faster pace and tie with Reebok apparel lines to create a stronger retail presence." While trying to cut costs, Reebok acknowledges the need to spend more on ads and product development (USA TODAY, 7/6).